Saturday, February 17, 2018 11:44:16 PM
BioElectronics Vice President of Sales Discusses Opioids and the Alternative Drug Free ActiPatch® Pain Therapy
Frederick News Online
Everett Jolly, CEO and host of “Stock Day” welcomes Keith Nalepka, Vice President of Sales and Marketing for BioElectronics Corporation (OTC Pink:BIEL) (the “Company”).
BioElectronics’ Vice President of Sales and Marketing explains that ActiPatch® the Company’s drug free medical device alternative to opioids has been approved by the respected United Kingdom’s National Health Service for reimbursement and that the Company and Care Pharmacies have launched its “Pharmacists Pain Management Consultations” in the US to help mitigate the drug crisis.
In its studies of UK patients, ActiPatch decreased medication use by 36% and professional office visits 58%. These studies show good evidence for reducing the need for opioid medications as well as the special needs costs of chronic pain suffers. Nalepka is hopeful that this clinical support will encourage UK, US, and other physicians to recommend the ActiPatch® as well as help springboard sales of the FDA cleared nonprescription device.
“ActiPatch is doing what it has always done providing safe and superior pain relief! My past success in pain products and retail leads me to believe that to get products into retail is a challenge for small companies but ActiPatch is a strong contender.” Anticipating a perfect storm, he states that “2018 is going to be a transformational year for this Company.”
https://news.frederickonline.us/Press-Releases/BioElectronics-Vice-President-of-Sales-Discusses-Opioids-and-the-Alternative-Drug-Free-ActiPatch-Pain-Therapy-136871
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM